Clinical trial
Randomized, Double-Masked, Parallel Group Study of P-321 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease Assessing Safety and Efficacy Over 28 Days
NCT02831387 is registered in ClinicalTrials.gov with Parion Sciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized, Double-Masked, Parallel Group Study of P-321 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease Assessing Safety and Efficacy Over 28 Days
- Lead sponsor
- Parion Sciences
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- July 31, 2016
- Completion date
- June 30, 2017
- Enrollment
- 47 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.
dry eye disease